Jeffrey Weiss is a Rheumatology/Immunology physician. ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
81 Irving Pl # 1f
New York, NY 100032208
Telephone
212-533-5090Registry record last updated 26 Feb 2019.
Clinical trials
- Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
Sponsor: MD Stem Cells
- Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
Sponsor: MD Stem Cells
- Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
Sponsor: MD Stem Cells
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- PFIZER INC.Program year20251 payment
- Amgen Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
38.1%Gabapentinoids14%Gabapentin100%Part D≥14 patientsOpioid Agonist13.6%Oxycodone Hcl100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
27.2%Nonsteroidal Anti-inflammatory Drug21%Diclofenac Sodium100%Part D≥21 patientsMuscle Relaxant6.2%Cyclobenzaprine Hcl100%Part D<11 patientsCancer & immunology
24.5%JAK inhibitor18.7%Xeljanz Xr100%Part D<11 patientsFolate Analog Metabolic Inhibitor5.8%Methotrexate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2005–2025 per NIH RePORTER. The latest:
- Vasopressin 2 receptors in the bat bladder: effects of age and biological sex on expression and function
Suny Downstate Medical Center
FY2025$162,200R03AG090922 - Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Icahn School of Medicine at Mount Sinai
FY2017$203,377R21AT008540 - Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults
Icahn School of Medicine at Mount Sinai
FY2016$257,476R21AT008540
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”